Revenue

The safety solutions leader adds a top CFO and CEO to its board, a strategic move to bolster financial oversight and drive growth amid record performance.

After a strategic pivot to focus purely on cell and gene therapy, BioLife reports strong revenue growth and a profitable quarter, eyeing further gains in 2026.

Neurizon Therapeutics has started dosing its promising ALS drug, NUZ-001, in the groundbreaking HEALEY Platform Trial, a pivotal step for patients.

Facing user burnout and fierce rivals, Tinder's first-ever product event aims to reignite the flame. Can new tech and a new vision save the dating giant?

The AI semiconductor firm posts 37% annual revenue growth and a return to non-GAAP profit, proving its strategic pivot to intelligent edge devices is a success.

Structure Therapeutics reports strong Phase 2 data for its oral obesity pill, aleniglipron, positioning it as a key contender in the race for pill-based GLP-1s.

The 3M spin-off navigates a transformative year, posting strong organic growth driven by MedSurg and Dental, despite a reported sales dip from divestitures.

A new study shows alternating magnetic fields can destroy antibiotic-resistant biofilms on medical implants, offering hope for a non-surgical treatment.

NuScale Power touts a 'breakthrough year' with landmark deals, but staggering financial losses and partner scrutiny test its path to commercialization.

The ad tech firm's stock surged on a strong Q4, but a full-year loss highlights its high-stakes pivot to AI and CTV to fuel future growth.

Clipper Realty's Q4 results show a stark divide in NYC real estate, as soaring apartment rents struggle to offset deep losses from its troubled office portfolio.

With Phase 3 epilepsy results for its lead drug azetukalner due in March, Xenon reveals a major R&D spend and a cash runway to fuel its broad pipeline.

Nearing 400 shops, the superfruit bowl brand's rapid growth is fueled by savvy franchisees, private equity backing, and a major push into global markets.

A critical vulnerability in the OpenClaw AI agent allowed any website to silently hijack developer tools, exposing a new and dangerous class of security risks.

The landmark multi-year deal with the US Open Pickleball Championships signals major corporate confidence in America's fastest-growing sport.

A Virginia tech firm's patent portfolio is valued at $18B, giving it foundational control over AI and 5G. What does this mean for the industry?

With clinical results converging, a new report reveals the real GLP-1 battle is fought in patent filings, not labs, deciding who wins this $100B+ market.

Intelligent power management firm Eaton raises its dividend 6%, backed by record 2025 earnings and a strategic focus on electrification and digitalization.

With its 'Women Who Inspire' campaign and a major brand refresh, Dress for Success is tackling global workforce disparities with a bold new vision.

With millions of Canadians suffering from dry eye, a new program combines advanced tech like IPL with personalized plans to offer hope and accessible relief.